Abbott Nutrition
B · 2.90Spinoff of Abbott (ABT) · Packaged Foods · Expected By end-2027
Similac, Ensure, PediaSure, Pedialyte and Glucerna, ~$8.5B of sales, spun tax-free by end-2027 under insider CEO Daniel Salvadori; debt and margins not yet disclosed
Snapshot Across Reports
| Oct 30, 2026 | |
|---|---|
| Status | Upcoming |
| Investment Grade | B (2.90) |
| Revenue | ~$8.5B |
| Expected Date | By end-2027 |
⚠ Auto-generated profile — not editorially reviewed.
This summary is compiled automatically from our tracked report data. A reviewed in-depth analysis is planned. For further detail ▸ read the Oct 30, 2026 report.